
“The U.S. Supreme Court ruled on Monday that makers of generic drugs already approved by the U.S. Food and Drug Administration cannot be held liable under state law for claims of design defects. In a 5-4 vote, the court ruled for Mutual Pharmaceutical Co, a unit of URL Pharma, owned by Sun Pharmaceutical Industries.”
Related posts:
Teacher tells police of pupil 'enchanted by anarchism', tips off his university
Court: Iceland doesn’t need to repay UK and Dutch depositors
US military plans migrant internment camps amid crackdown
Black Market Dollar Exchange Sparks Argentina Luxury Sales Crackdown
‘Utter chaos’: ICE arrests 114 in immigration raid at Ohio gardening company
West Virginia residents sickened after exposure to 'safe' water
Rooftop urban gardeners in Bangkok grow edible algae
Indiscriminate surveillance fosters distrust, conformity and mediocrity: research
Xe — formerly Blackwater — fined $7.5 million over arms case
The Latest Suburban Crime Wave
Pakistan ditches dollar for yuan in trade with China after Trump tweet
Virgin Galactic's SpaceShipTwo makes first powered flight
Russia unveils $25 billion oil pipeline to the Pacific
Bitcoin’s Washington problem
US announces $23 million bounty for African group leaders